We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$481M
AUM Growth
-$331M
Cap. Flow
-$439M
Cap. Flow %
-91.24%
Top 10 Hldgs %
33.95%
Holding
227
New
22
Increased
10
Reduced
145
Closed
42

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$8.17M
2
TRMB icon
Trimble
TRMB
+$7.43M
3
NVDA icon
NVIDIA
NVDA
+$7.09M
4
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$6.37M
5
MBB icon
iShares MBS ETF
MBB
+$6.33M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$32.7M
2
MSFT icon
Microsoft
MSFT
+$25.9M
3
LULU icon
lululemon athletica
LULU
+$19.8M
4
VEEV icon
Veeva Systems
VEEV
+$17.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$14.9M

Sector Composition

Rank Sector Weight
1 Technology 22.74%
2 Healthcare 19.11%
3 Consumer Discretionary 9.45%
4 Financials 7.79%
5 Consumer Staples 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMT icon
151
Lockheed Martin
LMT
$136B
$306K 0.06%
810
-400
-33% -$154K
TER icon
152
Teradyne
TER
$59.3B
$305K 0.06%
2,280
-88,930
-98% -$11.4M
XYZ
153
Block Inc
XYZ
$47.5B
$305K 0.06%
1,250
– –
GLOB icon
154
Globant
GLOB
$1.61B
$300K 0.06%
1,367
-3,048
-69% -$670K
EW icon
155
Edwards Lifesciences
EW
$51.7B
$299K 0.06%
2,891
-160
-5% -$15.1K
AB icon
156
AllianceBernstein
AB
$3.47B
$291K 0.06%
6,260
+30
+0.5% +$1.31K
ACN icon
157
Accenture
ACN
$108B
$285K 0.06%
968
+184
+23% +$52.7K
LRCX icon
158
Lam Research
LRCX
$390B
$280K 0.06%
4,300
-12,800
-75% -$808K
INFO
159
DELISTED
IHS Markit Ltd. Common Shares
INFO
$280K 0.06%
2,487
-4,245
-63% -$450K
BMO icon
160
Bank of Montreal
BMO
$127B
$277K 0.06%
2,700
– –
OEF icon
161
iShares S&P 100 ETF
OEF
$20.6B
$273K 0.06%
1,390
-1,990
-59% -$378K
PM icon
162
Philip Morris
PM
$295B
$263K 0.05%
2,651
-6,405
-71% -$615K
JKHY icon
163
Jack Henry & Associates
JKHY
$11.1B
$262K 0.05%
1,605
-1,605
-50% -$256K
FAST icon
164
Fastenal
FAST
$59.5B
$259K 0.05%
9,980
-10,480
-51% -$273K
PNR icon
165
Pentair
PNR
$11B
$258K 0.05%
3,825
+365
+11% +$24.1K
MRVL icon
166
Marvell Technology
MRVL
$196B
$255K 0.05%
+4,375
New +$214K
VGK icon
167
Vanguard FTSE Europe ETF
VGK
$31.4B
$254K 0.05%
3,770
-4,220
-53% -$285K
SPGI icon
168
S&P Global
SPGI
$120B
$246K 0.05%
599
-599
-50% -$230K
TSM icon
169
TSMC
TSM
$2.18T
$240K 0.05%
1,995
-3,705
-65% -$434K
CI icon
170
Cigna
CI
$74.6B
$237K 0.05%
1,000
– –
NEE icon
171
NextEra Energy
NEE
$177B
$237K 0.05%
3,234
-1,285
-28% -$96.4K
AMGN icon
172
Amgen
AMGN
$222B
$234K 0.05%
958
-252
-21% -$62K
EMR icon
173
Emerson Electric
EMR
$88.3B
$221K 0.05%
+2,293
New +$216K
MPC icon
174
Marathon Petroleum
MPC
$83.7B
$220K 0.05%
+3,640
New +$213K
MDT icon
175
Medtronic
MDT
$112B
$218K 0.05%
1,755
-2,543
-59% -$319K
5 6
7
8 9

Similar funds

BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
CP
Corbenic Partners Bethlehem, Pennsylvania $380M AUM 10.47% 1-Year Est. Return
BWM
BT Wealth Management Atlanta, Georgia $356M AUM 9.63% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return

Dixon Hubard Feinour & Brown's Q2 2021 Portfolio in Review

As of Q2 2021, Dixon Hubard Feinour & Brown held 227 positions worth $481M, down 41% from $812M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Dixon Hubard Feinour & Brown withdrew a net $439M in Q2 2021, closing 42 positions and reducing 145 holdings. Its most notable exit was Netflix, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Dixon Hubard Feinour & Brown opened a new position in CVS Health worth $8.32M.

  • Dixon Hubard Feinour & Brown's largest Q2 2021 buy was CVS Health: 99,762 shares worth $8.32M.
  • Dixon Hubard Feinour & Brown added most to NVIDIA in Q2 2021, an estimated $7.09M increase.
  • Dixon Hubard Feinour & Brown's biggest Q2 2021 reduction was Apple, cutting an estimated $32.7M.
  • Dixon Hubard Feinour & Brown fully exited Netflix in Q2 2021, selling an estimated $14.9M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 34% of its $481M portfolio in Q2 2021.
  • Dixon Hubard Feinour & Brown opened 22 new positions and closed 42 in Q2 2021.
  • Dixon Hubard Feinour & Brown's portfolio value fell 41% quarter-over-quarter to $481M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2021, filed 23 Aug 2021.